证券代码：600731 证券简称：湖南海利 公告编号：2024-022 A 股每股现金红利 0.2 元 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2024/6/24 | － | 2024/6/25 | 2024/6/25 | 差异化分红送转： 否 一、 通过分配方案的股东大会届次和日期 本次利润分配方案经公司 2024 年 4 月 26 日的 2023 年年度股东大会审议通过。 湖南海利化工股份有限公司 2023 年年度权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 每股分配比例 除公司自行发放对象外，其余股东的红利委托中国结算上海分公司通过其资金清算系统 向股权登记日上海证券交易所收市后登记在册并在上海证券交易所各会员办理了指定交易的 股东派发。已办理指定交易的投资者可于红利发放日在其指定的证券营业部领取现金红利， 未办理指定交易的股东红利暂由中国结算上海分公 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 湖南海利化工股份有限公司（以下简称"公司"）董事会于近日收到公司副 总经理李波先生的书面辞职报告，李波先生因个人原因申请辞去公司副总经理职 务，辞去上述职务后，仍在公司任职。 李波先生在担任公司副总经理期间恪尽职守、勤勉尽责，为公司的发展做出 了重大贡献,公司董事会对李波先生在任职期间为公司做出的贡献表示衷心感谢。 特此公告。 证券代码：600731 证券简称：湖南海利 公告编号：2024-021 湖南海利化工股份有限公司 关于李波先生辞去公司副总经理职务的公告 湖南海利化工股份有限公司董事会 2024年5月8日 ...

Financial Performance - The company's operating revenue for Q1 2024 was CNY 343,665,585.56, representing a decrease of 41.82% compared to the same period last year[5] - Net profit attributable to shareholders was CNY 9,697,183.57, down 88.63% year-on-year[5] - The net profit after deducting non-recurring gains and losses was CNY 6,156,716.62, a decline of 92.57% compared to the previous year[5] - Basic earnings per share decreased by 89.29% to CNY 0.0174[5] - Total revenue for Q1 2024 was ¥343,665,585.56, a decrease of 42% compared to ¥590,720,878.11 in Q1 2023[22] - Net profit for Q1 2024 was ¥8,186,519.75, a decline of 90% from ¥84,444,969.15 in Q1 2023[23] - Operating profit for Q1 2024 was ¥14,050,948.72, a decrease of 86% compared to ¥102,734,549.53 in Q1 2023[22] - The company reported a total comprehensive income of ¥8,186,519.75 for Q1 2024, down from ¥84,444,969.15 in Q1 2023[23] Cash Flow and Assets - The net cash flow from operating activities was negative at CNY -163,875,077.77, a decrease of 379.68% year-on-year[5] - Cash flow from operating activities for Q1 2024 was negative at -¥163,875,077.77, compared to positive cash flow of ¥58,592,906.66 in Q1 2023[24] - Cash and cash equivalents decreased to RMB 832,017,591.39 from RMB 1,061,578,890.17, representing a decline of approximately 21.6%[16] - Cash and cash equivalents at the end of Q1 2024 were ¥827,696,479.40, down from ¥1,367,753,660.41 at the end of Q1 2023[25] - The company's current assets totaled RMB 2,142,579,000.43, down from RMB 2,342,164,479.43, indicating a decrease of about 8.5%[16] - Total assets at the end of the reporting period were CNY 4,217,929,859.48, down 4.19% from the end of the previous year[6] - As of March 31, 2024, the total assets of Hunan Haili Chemical Co., Ltd. amounted to RMB 4,217,929,859.48, a decrease from RMB 4,402,336,693.11 as of December 31, 2023, reflecting a decline of approximately 4.2%[18] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 28,034[12] - The largest shareholder, Hunan Haili High-tech Industry Group Co., Ltd., holds 23.50% of the shares, totaling 131,306,849 shares[12] Liabilities and Equity - Total liabilities decreased to RMB 1,068,825,540.95 from RMB 1,262,730,795.16, a decline of about 15.3%[18] - The company's equity attributable to shareholders increased slightly to RMB 3,015,814,617.72 from RMB 3,004,900,926.46, reflecting a growth of approximately 0.4%[18] - The total current liabilities decreased to RMB 514,604,577.29 from RMB 708,791,470.92, a reduction of approximately 27.4%[18] Expenses - Total operating costs for Q1 2024 were ¥332,813,010.01, down 32% from ¥491,124,993.89 in Q1 2023[22] - Research and development expenses for Q1 2024 were ¥26,491,472.23, a decrease of 14% from ¥30,825,402.00 in Q1 2023[22] - The company reported a significant decrease in employee compensation payable, which fell to RMB 35,683,478.48 from RMB 87,961,267.33, a decline of about 59.5%[18] Non-Recurring Items - The company received government subsidies amounting to CNY 3,952,811.55, which are closely related to its normal business operations[8] - The company did not report any net profit from subsidiaries in the current quarter, consistent with the previous year[24] Return on Equity - The weighted average return on equity decreased to 0.32%, down 3.03 percentage points from the previous year[6]

证券代码：600731 证券简称：湖南海利 公告编号：2024-020 湖南海利化工股份有限公司 2024 年 1-3 月主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据上海证券交易所《上海证券交易所上市公司自律监管指引第 3 号行业信息 披露：第十三号——化工》和相关通知的要求，湖南海利化工股份有限公司（以下 简称"公司"）现将 2024 年 1-3 月主要经营数据公告如下： 一、主要产品的产量、销量及收入实现情况 | 主要产品 | 2024 | 年 1-3 | 月产量 | 2024 年 1-3 | 月销量 | 2024 | 年 1-3 | 月销售 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | （吨） | | （吨） | | | 金额（万元） | | | 氨基甲酸酯类 | | 2,172.12 | | 909.13 | | | 8,473.72 | | | 杂环类 | | 1,330.80 | | 829.25 | ...

致：湖南海利化工股份有限公司 长沙市岳麓区潇湘北路三段 859 号 福晟金融中心 30-32 楼 湖南弘一律师事务所 关于湖南海利化工股份有限公司 2023 年年度股东大会的法律意见书 湖南海利化工股份有限公司（以下简称"公司"）2023 年年度股东大会（以 下简称"本次股东大会"）于 2024 年 4 月 26 日（星期五）在长沙市芙蓉中路 二段 251 号湖南海利第 1 办公楼 6 楼会议室召开。湖南弘一律师事务所（以下简 称"本所"）接受公司委托，指派本所律师对本次股东大会的合法性进行见证并 出具法律意见。根据《中华人民共和国公司法》（以下简称"《公司法》"）、 《上市公司股东大会规则（2022 年修订）》（以下简称"《股东大会规则》"） 等法律法规、其他规范性文件以及《湖南海利化工股份有限公司章程》（以下简 称"《公司章程》"）的规定，就本次股东大会的召集和召开程序、召集人及出 席会议人员的资格、会议议案、表决方式和表决程序、表决结果和会议决议等出 具法律意见书。 为出具本法律意见书，本所律师对本次股东大会所涉及的有关事项进行了审 查，查阅了相关会议文件，并对有关问题进行了必要的核查和验证。 公司已向 ...

证券代码：600731 证券简称：湖南海利 公告编号：2024-017 湖南海利化工股份有限公司 2023 年年度股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 | 1、出席会议的股东和代理人人数 | 20 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 134,223,349 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 24.0224 | (四) 表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次会议由公司董事会召集，由公司董事长肖志勇先生主持。本次会议的召 (一) 股东大会召开的时间：2024 年 4 月 26 日 (二) 股东大会召开的地点：长沙市芙蓉中路二段 251 号湖南海利第 1 办公楼 6 楼会议室 (三) 出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： 集、召开、表决方式符合有关法律、行政法规、部 ...

Hunan Haili Chemical Industry Co.,Ltd. 湖 南 海 利 化 工 股 份 有 限 公 司 2023 年年度股东大会会议资料 湖南海利 2024 年 4 月 26 日 湖南海利化工股份有限公司 2023 年年度股东大会会议文件 2024 年 4 月 26 日 目录 | | | 会议日程安排表 2 | | --- | --- | --- | | 议案 | 1：《公司 | 2023 年度董事会工作报告》 3 | | 议案 | 2：《公司 | 2023 年度监事会工作报告》… 8 | | 议案 | 3：《公司 | 年年度报告及年报摘要》 12 2023 | | 议案 | 4：《公司 | 2023 年度财务决算报告》 13 | | 议案 | 5：《公司 | 2023 年度利润分配预案》 15 | | 议案 | 6：《关于 | 年度公司董事薪酬的议案》 16 2024 | | 议案 | 7：《关于 | 2024 年度公司监事薪酬的议案》 17 | | 议案 | | 8：《关于续聘会计师事务所及 2024 年度支付会计师事务所报酬的议案》..18 | | 议案 | | 9：《关于为子公司 ...

证券代码：600731 证券简称：湖南海利 公告编号：2024-016 湖南海利化工股份有限公司 关于召开 2023 年度业绩暨现金分红说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 投资者可于 2024 年 04 月 18 日(星期四)至 04 月 24 日(星期 三)16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或 通过公司邮箱 sh600731@sina.com 进行提问。公司将在说明会上对投 资者普遍关注的问题进行回答。 湖南海利化工股份有限公司（以下简称"公司"）已于 2024 年 4 月 2 日发布公司 2023 年度报告，为便于广大投资者更全面深入地了 解公司 2023 年度经营成果、财务状况，公司计划于 2024 年 04 月 25 日下午 16:00-17:00 举行 2023 年度业绩暨现金分红说明会，就投资 者关心的问题进行交流。 一、 说明会类型 会议召开时间：2024 年 04 月 25 日(星期四)下午 16:00-17:00 会议召开地点： 上海证券 交 ...

招商证券股份有限公司 关于湖南海利化工股份有限公司 | 保荐机构名称： | 招商证券股份有限公司 | | --- | --- | | 被保荐公司证券代码： | 600731.SH | | 证券简称： | 湖南海利 | | 保荐代表人： | 姓名：吴茂林 | | | 联系方式：0755-83081306 | | | 联系地址：深圳市福田区福田街道福华一路111号 | | 保荐代表人： | 姓名：褚四文 | | | 联系方式：0755-83081306 | | | 联系地址：深圳市福田区福田街道福华一路111号 | 2023 年持续督导年度报告书 经中国证券监督管理委员会（以下简称"中国证监会"）《关于核准湖南海利 化工股份有限公司非公开发行股票的批复》（证监许可[2022]2671 号核准）核准， 湖南海利化工股份有限公司（（以下简称"湖南海利"、"上市公司"或"公司"）非公 开发行人民币普通股 96,952,908.00 股，每股发行价格为人民币 7.22 元，共计募 集资金总额为 699,999,995.76 元，扣除发行费用 14,155,615.89 元（不含税）后， 本次募集资金净额为 685,844 ...

Financial Performance - The company achieved a net profit of ¥273,777,847.66 for the year 2023, with an unallocated profit of ¥1,090,142,075.26 at year-end[8] - The proposed cash dividend for 2023 is ¥2 per 10 shares, totaling ¥111,748,483.20, which represents 40.82% of the net profit attributable to shareholders[8] - The company's operating revenue for 2023 was CNY 2,374,351,376.60, a decrease of 24.14% compared to CNY 3,130,113,836.77 in 2022[32] - The net profit attributable to shareholders for 2023 was CNY 273,777,847.66, down 22.28% from CNY 352,269,305.76 in 2022[32] - The net profit after deducting non-recurring gains and losses decreased by 47.11% to CNY 184,434,195.93 in 2023 from CNY 348,697,038.31 in 2022[35] - The basic earnings per share for 2023 was CNY 0.4972, a decline of 34.82% from CNY 0.7628 in 2022[33] - The diluted earnings per share also decreased by 34.82% to CNY 0.4972 in 2023 from CNY 0.7628 in 2022[35] - The weighted average return on equity dropped to 9.74% in 2023, down 8.91 percentage points from 18.65% in 2022[35] - Total assets at the end of 2023 were CNY 4,402,336,693.11, an increase of 12.15% from CNY 3,925,429,646.80 at the end of 2022[32] - The net assets attributable to shareholders increased by 46.88% to CNY 3,004,900,926.46 at the end of 2023 from CNY 2,045,866,835.50 at the end of 2022[32] Risk Management - The company faces risks including policy, market, operational, and financial risks, which are detailed in the management discussion section[12] - The company emphasizes the importance of investment risk awareness due to uncertainties in forward-looking statements[9] - The company has established risk management policies to identify and analyze risks, including market risk, credit risk, and liquidity risk[140] - The company is exposed to market competition risks due to the fragmented nature of the agricultural chemical industry and the entry of new competitors[129] - The reliance on international markets presents risks, including increased tariffs and trade barriers that could affect export revenues[132] - Environmental protection policies pose a risk, as stricter regulations could lead to increased operational costs and potential penalties for non-compliance[127] - Changes in tax incentives for high-tech enterprises could significantly impact the company's profitability[128] Operational Efficiency - The company has implemented cost reduction measures and optimized project management to enhance operational efficiency[47] - The company is actively pursuing cost reduction and efficiency improvement strategies in response to market challenges[91] - The company aims to reduce operational costs by 5% through process optimization and automation initiatives[164] - The company has a total of 992 production personnel, 105 sales personnel, and 354 technical personnel among its workforce[192] Research and Development - Research and development expenses totaled 122 million yuan, representing an R&D intensity of 5.13%, with 249 research projects undertaken and 28 new patents applied for[49] - The company holds a total of 268 valid patents, including 232 invention patents, showcasing its commitment to innovation and technology development[59] - The company has developed 97 A-level insecticidal and acaricidal active compounds and 65 A-level fungicidal active compounds as part of its green product innovation strategy[96] - The company is currently working on a new green bionic insecticide for controlling major pests, which is part of a provincial key research and development plan[96] - The company plans to invest 200 million yuan in new technology development over the next two years[164] Market Position and Strategy - The company is recognized as a leading domestic producer of carbamate pesticides, with a strong market share and a complete industrial chain[60] - The company aims to enhance its competitiveness through innovation, focusing on the development of new materials and expanding into strategic emerging industries[116] - The company is expanding its market presence in Southeast Asia, targeting a 30% market share by 2025[164] - A strategic acquisition of a local competitor was completed, expected to enhance operational efficiency and increase market penetration by 15%[164] Governance and Compliance - The company has established a performance evaluation and incentive mechanism for directors, supervisors, and senior management[153] - The company adheres to strict information disclosure regulations, ensuring accurate and timely reporting of financial data to protect investors' rights[154] - The company is committed to protecting the rights of minority shareholders and ensuring equitable access to information[154] - The company has implemented measures to prevent the controlling shareholder from occupying company funds and infringing on its interests[152] Employee Development - The company has a multi-level compensation incentive policy that links employee salaries to company performance and individual performance[193] - The company plans to implement more comprehensive talent development programs in 2023 to enhance human resource capabilities and effectiveness[194] - The total remuneration for senior management during the reporting period amounted to 558.5923 million yuan, reflecting the company's commitment to competitive compensation[161] Future Outlook - The company provided a forward guidance of 10% revenue growth for the next fiscal year, projecting revenues to reach approximately 1.32 billion yuan[164] - The company reported a significant increase in revenue, achieving a total of 1.5 billion yuan in 2023, representing a 15% year-over-year growth[167] - The company provided a positive outlook for 2024, projecting a revenue growth of 10% to 1.65 billion yuan[167]